The Genetic Interrogation: Molecular Oncology Testing for Solid Tumors
We no longer classify tumors solely by the organ they originated in; we classify them by the specific, microscopic spelling errors in their DNA. If you do not test the tumor’s genetics, you cannot prescribe the correct drug. Molecular Oncology Testing for Solid Tumors: A Pragmatic Approach is a brutally efficient, highly clinical laboratory manual detailing exactly how to extract and sequence this data. This volume provides the precise pathological blueprints required to navigate the exploding complexity of Next-Generation Sequencing (NGS) without getting lost in the noise.
Mastering the Actionable Mutation
The core philosophy of this text is clinical relevance over theoretical data. The authors aggressively detail the mechanics of the genetic report. It dictates exactly how an oncologist must read a 10-page genomic readout from a lung tumor, teaching them to instantly ignore the dozens of irrelevant “passenger” mutations and isolate the single, targetable “driver” mutation (like ALK or ROS1) that legally justifies the prescription of a life-saving targeted pill.
Navigating the Liquid Biopsy
The book provides a masterclass in non-invasive tracking. It dictates the exact laboratory pathways for circulating tumor DNA (ctDNA). It rigorously explores the revolutionary technology of drawing a vial of blood from a patient’s arm to hunt for microscopic fragments of cancer DNA floating in the plasma, allowing the oncologist to detect if the tumor has mutated to become resistant to chemotherapy weeks before the tumor physically grows on a CT scan.
Frequently Asked Questions (FAQs)
Is this a massive, theoretical textbook on the history of genetics?
No, it is a strictly *pragmatic, clinical pathology, and translational oncology manual* designed to teach physicians exactly how to order and interpret genetic tests for their patients today.
Who is the primary audience?
It is an essential, mandatory daily reference for Medical Oncologists, Molecular Pathologists, Oncology Pharmacists, and Translational Researchers.
